Literature DB >> 25126127

Primary Ewing's sarcoma of cervical vertebra: An uncommon presentation.

Sonia Chhabra1, Sunita Singh1, Divya Sethi1, Qury Sabita Mahapatra1.   

Abstract

Ewing's sarcoma is a malignant primary bone tumor primarily seen in the long bones. Primary Ewing's sarcoma of the cranium is quite uncommon occurring in 1% of the cases. We report the occurrence of this rare lesion in a 24-year-old male presenting with progressively increasing swelling in left mastoid region mimicking a mastoid abscess which was later diagnosed on Fine needle aspiration cytology (FNAC) as a small round cell tumor as Ewing's sarcoma. Contrast enhanced computed tomography (CECT) revealed a typical moth eaten appearance in the first and second cervical vertebra.

Entities:  

Keywords:  Ewing's sarcoma; primary cervical vertebra tumor; tumor of atlas vertebra

Year:  2014        PMID: 25126127      PMCID: PMC4129586          DOI: 10.4103/1793-5482.136725

Source DB:  PubMed          Journal:  Asian J Neurosurg


  4 in total

1.  Primary malignant neoplasms.

Authors:  K Subbarao; H G Jacobson
Journal:  Semin Roentgenol       Date:  1979-01       Impact factor: 0.800

2.  Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment.

Authors:  Andac Argon; Mert Basaran; Fulya Yaman; Yavuz Dizdar; Burak Sakar; Hakan Camlica; Sevil E Bavbek; Harzem Ozger; Emin Darendeliler; Haluk Onat
Journal:  Jpn J Clin Oncol       Date:  2004-11       Impact factor: 3.019

Review 3.  From the archives of the AFIP. Primary tumors of the spine: radiologic pathologic correlation.

Authors:  M D Murphey; C L Andrews; D J Flemming; H T Temple; W S Smith; J G Smirniotopoulos
Journal:  Radiographics       Date:  1996-09       Impact factor: 5.333

4.  Ewing's sarcoma of the vertebral column.

Authors:  M V Pilepich; T J Vietti; M E Nesbit; M Tefft; J Kissane; O Burgert; D Prichard; E A Gehan
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-01       Impact factor: 7.038

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.